BMS grabs bigger market territory for cancer antibody; Biotech vet Dionne joins Third Rock entrepreneur team;

@FierceBiotech: Report: Just 10% of drug moving through trials between 2003 and 2010 were approved by FDA. Oncology drugs faced toughest road. More | Follow @FierceBiotech

@JohnCFierce: Creating co. on bleeding edge of a new technology can cut both ways. PacBio axes 130 jobs, slams brakes on spending. News | Follow @JohnCFierce

@RyanMFierce: I hope to see lots of Boston biotechies at Oct. 19 breakfast featuring R&D heads at Biogen, Vertex and @JohnCFierce. Info | Follow @RyanMFierce

@MaureenFierce: RT @thecortex: Merck boss uses 12 different names for "job-cut" in memo. Report | Follow @MaureenFierce

> Bristol-Myers Squibb has expanded its commercial footprint on an experimental cancer treatment partnered with Japan's Ono. Its expanded its territorial rights to develop and commercialize the anti-PD-1 antibody known as BMS-936558/ONO-4538 to the global market, excepting only Japan, Korea and Taiwan. BMS snagged the drug in its acquisition of Medarex. Release

> Keith Dionne, the former CEO at Surface Logix, has joined Third Rock as an entrepreneur-in-residence. Dionne is a longtime biotech player and a veteran of Millennium, so he'll be a familiar face to many at Third Rock. Release

> Zafgen, the virtual Cambridge, MA-based biotech out to come up with a therapeutic alternative to bariatric surgery in treating obesity, named Dr. Dennis Kim as its chief medical officer. Zafgen release

> Viiv Healthcare has withdrawn European and U.S. applications for "once-daily administration of Celsentri/Selzentry [maraviroc] tablets in treatment-experienced patients infected with only CCR5-tropic HIV-1." Story

> Sanofi Pasteur is donating a vaccine strain used for polio eradication to the World Health Organization. Release

Pharma News

@FiercePharma: Scientists who worked on targeted leukemia meds--Novartis' Gleevec, BMS' Sprycel--make Nobel predictions list Story | Follow @FiercePharma

> Pfizer blames Spanish job cuts on pricing policies. Article

> U.K. pharma pushes back against value-based pricing. Item

Medical Device News

@FierceMedDev: Medtronic awarded $101.2M in patent infringement case. Article | Follow @FierceMedDev

> Boston Sci prevails in lawsuit over sales group. Story

> Former Wright exec takes reins at Intrinsic. Report

Drug Delivery News

> Feds back nasal med for cyanide poisoning. Report

> Lasers craft neuron-delivery 'trucks' for Alzheimer's. Piece

> Ultrasound could aid delivery of drugs into brain. Item

> Alkermes wraps buyout of Elan drug-delivery biz. Story

> Unigene, Tarsa score Ph3 win with oral peptide drug. Item

> Sanofi fuels microneedle trend with flu vax. More

And Finally... Researchers say that yawning varies with the season, suggesting it may be a simple method the body relies on to regulate brain temperature. Release